 Pharmacokinetic disposition zidovudine pregnancy Zidovudine pharmacokinetics human immunodeficiency virus type women zidovudine mg weeks pregnancy postpartum Zidovudine concentrations high-pressure liquid chromatography pharmacokinetic analyses model-independent methods pregnant versus postpartum periods peak zidovudine levels SD mumol/l versus mumol/l elimination half-lives versus areas concentration curve mumol/l mumol/l apparent total body clearances l/h/kg l/h/kg apparent steady state volumes distribution l/kg l/kg Umbilical cord serum levels maternal levels persistent adverse effects zidovudine therapy women babies